Stranger than fiction.

Shares soar 54.9% after Electronic Arts makes a buyout offer.

Oppenheimer analyst Meredith Whitney was among those predicting a continued turbulent road for the banking giant.

The sector rallies late after S&P affirms the triple-A ratings on Ambac and MBIA.

Genentech’s new Avastin approval helps lift the biotech sector.

The credit card company’s IPO is a buying opportunity, Cramer says.

The company has to resolve a tax issue before reporting its full fourth-quarter results.

It’s the first victory since December for the bulls in TheStreet.com RealMoney Barometer.

Stocks surge after S&P affirms its ratings on troubled MBIA and Ambac.

Agria climbs on raised revenue outlook.

Analysts wonder if a spinoff is in the future.